Artificial Intelligence will revolutionise eye screenings

Artificial Intelligence (AI) supports eye specialists work and minimises screening costs

Extensive adoption of AI will be one of the most significant changes in health care in the coming years. AI-algorithms support ophthalmologists and other eye specialists in eye screening, image grading, diagnosing and treatment planning. It is possible to replace the first-line grader with AI and free eye specialist resources to focus on the ones with the disease.

Artificial Intelligence improves the quality and accessibility to eye screenings

With AI it is possible to extend diabetic retinopathy screenings to reach wider patient groups as well as diagnosing other eye diseases such as suspected glaucoma or age-related macular degeneration (AMD).  In addition to eye diseases, by analysing retinal images with AI it will be possible to also detect signs and risk factors of various cardiovascular and neurological diseases. Due to this, the importance of retinal imaging will significantly increase in primary care in the future.

Our AI strategy is based on strong partnerships and own development work

We develop our AI solutions and algorithms in close co-operation with our international partner network. In addition to our own internally developed algorithms, our AI solutions consist of various algorithms that are developed and thoroughly validated by world-leading partner companies and research teams. As a result of this international partner network, Optomed is able to provide extensive and reliably clinically validated AI solutions to its customers globally.